Sanofi (SNY)
42.40
-0.93
(-2.15%)
USD |
NASDAQ |
Sep 15, 16:00
42.44
+0.04
(+0.09%)
After-Hours: 07:19
Sanofi Price : 42.40 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 42.78 | 42.89 | 42.38 | 42.40 | 2.683M |
| Sep 14, 2026 | 43.70 | 43.74 | 43.02 | 43.33 | 2.328M |
| Sep 11, 2026 | 42.81 | 42.88 | 42.41 | 42.77 | 2.373M |
| Sep 10, 2026 | 42.86 | 43.05 | 42.67 | 42.72 | 1.960M |
| Sep 09, 2026 | 43.08 | 43.46 | 42.82 | 42.85 | 1.947M |
| Sep 08, 2026 | 43.49 | 43.71 | 43.14 | 43.16 | 2.600M |
| Sep 04, 2026 | 44.17 | 44.36 | 44.02 | 44.24 | 1.695M |
| Sep 03, 2026 | 45.15 | 45.16 | 44.20 | 44.33 | 2.404M |
| Sep 02, 2026 | 44.68 | 45.22 | 44.43 | 44.47 | 2.170M |
| Sep 01, 2026 | 45.08 | 45.23 | 44.20 | 44.37 | 2.015M |
| Aug 31, 2026 | 44.59 | 44.69 | 44.26 | 44.36 | 2.345M |
| Aug 28, 2026 | 44.93 | 44.96 | 44.65 | 44.82 | 1.359M |
| Aug 27, 2026 | 44.86 | 45.08 | 44.72 | 44.84 | 2.291M |
| Aug 26, 2026 | 46.01 | 46.04 | 45.39 | 45.42 | 1.628M |
| Aug 25, 2026 | 45.73 | 46.05 | 45.57 | 46.02 | 1.241M |
| Aug 24, 2026 | 45.49 | 45.78 | 45.32 | 45.69 | 1.720M |
| Aug 21, 2026 | 45.26 | 46.11 | 45.25 | 45.85 | 1.861M |
| Aug 20, 2026 | 45.65 | 45.74 | 45.06 | 45.15 | 2.598M |
| Aug 19, 2026 | 45.42 | 46.02 | 45.42 | 45.83 | 2.741M |
| Aug 18, 2026 | 45.10 | 45.22 | 44.74 | 44.97 | 3.171M |
| Aug 17, 2026 | 44.00 | 44.42 | 43.82 | 44.41 | 1.928M |
| Aug 14, 2026 | 43.51 | 43.80 | 43.24 | 43.72 | 2.719M |
| Aug 13, 2026 | 43.93 | 44.10 | 43.73 | 43.78 | 2.214M |
| Aug 12, 2026 | 43.49 | 43.78 | 43.34 | 43.71 | 2.931M |
| Aug 11, 2026 | 43.62 | 43.90 | 43.43 | 43.56 | 2.840M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 161.85 |
| GSK Plc | 50.01 |
| Eli Lilly & Co. | 1136.11 |
| Merck & Co., Inc. | 143.79 |
| Novo Nordisk A/S | 42.53 |
Price Related Metrics
| PE Ratio | 21.84 |
| PS Ratio | 1.916 |
| PEG Ratio | 3.102 |
| Price to Book Value | 1.428 |
| Price to Free Cash Flow | 10.36 |
| Earnings Yield | 4.58% |
| Market Cap | 102.96B |
| PEGY Ratio | 1.712 |
| Operating PE Ratio | 7.052 |
| Normalized PE Ratio | 12.34 |